G. Ahluwalia

发表

Synergy of Eflornithine Cream with Laser and Light-Based Systems for Hair Management

D. Shander, G. Ahluwalia, 2009 .

Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.

J. Tomaszewski, D. Cooney, D. Johns, 1991, Cancer research.

Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.

D. Cooney, M. Zhang, D. Johns, 1993, Cancer research.

Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.

G. Ahluwalia, 2013, The journal of investigative dermatology. Symposium proceedings.

Apoptosis in the hair follicle.

D. Shander, N. Botchkareva, G. Ahluwalia, 2006, The Journal of investigative dermatology.

Effect of Laser and Light-Based Systems on Hair Follicle Biology

N. Botchkareva, G. Ahluwalia, 2009 .

Survivin in the human hair follicle.

M. Kahn, D. Shander, N. Botchkareva, 2007, The Journal of investigative dermatology.

Metabolism and action of amino acid analog anti-cancer agents.

J. Grem, D. Cooney, Z. Hao, 1990, Pharmacology & therapeutics.

Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.

S. Broder, M. Connelly, M. Johnson, 1988, The Journal of biological chemistry.

Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.

D. Carney, D. Cooney, H. Jayaram, 1985, The Journal of clinical investigation.

Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52‐week open label REVEAL trial

L. Baumann, Z. Draelos, M. Gold, 2018, Journal of the American Academy of Dermatology.

Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.

R. K. Robins, V. Marquez, D. Cooney, 1982, Biochemical pharmacology.

Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.

A. Rhoads, G. Ahluwalia, 1982, Biochemical pharmacology.

Particulate cyclic 3',5'-nucleotide phosphodiesterase and calmodulin of cardiac muscle.

A. Rhoads, G. Ahluwalia, M. Lulla, 1984, The International journal of biochemistry.

Modulation of metabolism and anti-HIV-1 activity of purine 2',3'-dideoxynucleosides by IMP dehydrogenase inhibitors.

B. Robbins, A. Fridland, H. Mitsuya, 1991, Advances in experimental medicine and biology.

Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine.

M. Currens, D. Cooney, A. Fridland, 1990, Biochemical and biophysical research communications.

PART IV. BIOCHEMISTRY AND EVALUATION OF ANTI-HIV THERAPEUTICS

V. Marquez, J. Driscoll, D. Cooney, 2006 .

Metabolism in Human Leukocytes of Anti‐HIV Dideoxypurine Nucleosides a

V. Marquez, J. Driscoll, D. Cooney, 1990, Annals of the New York Academy of Sciences.

Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.

S. Broder, D. Cooney, A. Fridland, 1991, Molecular pharmacology.

Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.

S. Broder, D. Cooney, A. Fridland, 1987, Biochemical pharmacology.

Decay rates of anti-HIV dideoxynucleotides in tissue culture systems: a simple correction for the effect of cell replication.

R. Dedrick, J. Driscoll, P. Morrison, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin.

J. Plowman, D. Cooney, H. Jayaram, 1984, Biochemical pharmacology.

Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.

V. Marquez, D. Cooney, R. L. Dion, 1985, Journal of medicinal chemistry.

Prostaglandin D2 Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia

G. FitzGerald, S. Fischer, Yaping Liu, 2012, Science Translational Medicine.

Removal of Unwanted Facial Hair

J. Oblong, P. Styczynski, G. Ahluwalia, 2009 .

Treatment of Pseudofolliculitis Barbae

D. Shander, G. Ahluwalia, 2009 .

Management of Unwanted Hair

G. Ahluwalia, 2009 .

Dermal Safety of Laser and Light-Based Systems

J. Nash, M. Ward, G. Ahluwalia, 2009 .

Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine.

S. Broder, R. Yarchoan, D. Cooney, 1993, Drug metabolism and disposition: the biological fate of chemicals.

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

S. Broder, J. Balzarini, D. Cooney, 1986, Biochemical pharmacology.

Metabolites of tiazofurin as mediators of its biochemical and pharmacologic effects

D. Cooney, H. Jayaram, G. Ahluwalia, 1987 .

2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.

H. Mitsuya, S. Broder, C. Perno, 1990, Molecular pharmacology.

Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.

D. Cooney, A. Fridland, D. Johns, 1992, Molecular Pharmacology.

Comparison of the DNA Incorporation in Human MOLT-4 Cells of Two 2′-β-Fluoronucleosides, 2′-β-Fluoro-2′,3′-dideoxyadenosine and Fialuridine

J. Driscoll, D. Johns, H. Ford, 1996 .

2',3'-Didehydro-3'-deoxythymidine: regulation of its metabolic activation by modulators of thymidine-5'-triphosphate biosynthesis.

H. Mitsuya, W. Gao, D. Johns, 1996, Molecular Pharmacology.

Studies on the mechanism of action of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). VI. Biochemical and pharmacological studies on the degradation of thiazole-4-carboxamide adenine dinucleotide (TAD).

V. Marquez, D. Cooney, H. Jayaram, 1986, Biochemical pharmacology.

Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.

M. Cohen, J. Mcmahon, J. Balzarini, 1986, Cancer research.

The disposition and metabolism of tiazofurin in rodents, rabbits, and dogs.

G. Harper, D. Cooney, L. Malspeis, 1984, Drug metabolism and disposition: the biological fate of chemicals.

Enzyme Applications, Therapeutic

D. Cooney, H. Jayaram, G. Ahluwalia, 2000 .

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects.

L. Baumann, D. Wirta, S. Bruce, 2015, The Journal of clinical and aesthetic dermatology.

Long‐term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy‐induced eyelash hypotrichosis: a randomized controlled trial

P. Hossain, W. Perkins, T. Griffiths, 2015, The British journal of dermatology.

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.

Z. Draelos, L. Kircik, K. Grande, 2018, Journal of drugs in dermatology : JDD.

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.

L. Baumann, D. Goldberg, Joely Kaufman, 2018, Journal of drugs in dermatology : JDD.

Characterization of 2',3'-dideoxycytidine diphosphocholine and 2',3'-dideoxycytidine diphosphoethanolamine. Prominent phosphodiester metabolites of the anti-HIV nucleoside 2',3'-dideoxycytidine.

S. Musser, C. Perno, J. Kelley, 1993, Drug metabolism and disposition: the biological fate of chemicals.

Development of the Alopecia Areata Scale for Clinical Use: Results of an Academic-Industry Collaborative Effort.

J. Ko, J. Shapiro, A. Tosti, 2021, Journal of the American Academy of Dermatology.

2 Structure and function of hair

G. Ahluwalia, 2011 .

Efficacy and safety of etrasimod, a sphingosine 1‐phosphate receptor modulator, in adults with moderate‐to‐severe atopic dermatitis (ADVISE)

J. Silverberg, D. Murrell, R. Bissonnette, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials

L. Baumann, Z. Draelos, L. Kircik, 2018, Journal of drugs in dermatology : JDD.

Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment.

M. Lebwohl, M. Gold, B. Biesman, 2018, Journal of the American Academy of Dermatology.

Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.

J. Dover, D. Goldberg, E. Tanghetti, 2018, Journal of drugs in dermatology : JDD.

Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea.

J. Dover, T. Jones, R. Weiss, 2018, Journal of drugs in dermatology : JDD.

Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.

M. Attar, G. Ahluwalia, Janet DuBois, 2018, Journal of drugs in dermatology : JDD.

Studies on the mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) in mammalian lymphoblasts.

K. Paull, J. Barchi, D. Cooney, 1996, Journal of experimental therapeutics & oncology.

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

H. Mitsuya, S. Broder, J. Mcmahon, 1986, Biochemical pharmacology.

Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.

T. Shirasaka, J. Driscoll, D. Cooney, 1994, Molecular Pharmacology.

Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides.

J. Driscoll, D. Cooney, H. Mitsuya, 1993, Molecular Pharmacology.

A . Garza Men with Androgenetic Alopecia Inhibits Hair Growth and Is Elevated in Bald Scalp of 2

G. FitzGerald, S. Fischer, Yaping Liu, 2012 .

W. Perkins, F. Beddingfield, G. Ahluwalia, 2015, The British journal of dermatology.